AACR journals editors Robert Kruger and Elizabeth McKenna share how they're working to strengthen ties with the research...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
The year was 1909. Tuberculosis was a leading cause of death in America, but advances in medical care had...
For all of the incredible breadth of cancer research that the AACR supports, we draw inspiration from the countless...
Guest Post by Kelsey Hampton, BS Member of the AACR’s Associate Member Council-led Communications Committee
Guest Post by Sarah Junco Wong, PhD Member of the AACR’s Associate Member Council-led Communications Committee
This year marks the fourth year that AACR will be inducting newly elected Fellows into its AACR Academy. The...
This post, originally featured on the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center blog “Cancer Matters," applauds the launch...
Myeloma is the third most common blood cancer in the United States, arising in the plasma cells of the...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
In the third post of the “Meet the Chairs” series, Anna Barker, PhD, chair of the AACR Scientist↔Survivor Program...